ES2056789T3 - Inhibicion de la ruta de la 5-lipoxigenasa. - Google Patents
Inhibicion de la ruta de la 5-lipoxigenasa.Info
- Publication number
- ES2056789T3 ES2056789T3 ES86309672T ES86309672T ES2056789T3 ES 2056789 T3 ES2056789 T3 ES 2056789T3 ES 86309672 T ES86309672 T ES 86309672T ES 86309672 T ES86309672 T ES 86309672T ES 2056789 T3 ES2056789 T3 ES 2056789T3
- Authority
- ES
- Spain
- Prior art keywords
- lipoxigenasa
- inhibition
- route
- inhibit
- tiazina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
- Feed For Specific Animals (AREA)
- Organic Insulating Materials (AREA)
Abstract
UN IMIDAZOL CON UN DIARILO SUSTITUIDO CONDENSADO CON UN ANILLO DE TIAZOL, PIRROL, TIAZINA O PIRIDINA, O COMPOSICIONES FARMACEUTICAS DEL MISMO, SON UTILES PARA INHIBIR LA VIA DE 5-LIPOXIGENASA EN UN ANIMAL QUE LO NECESITE, MEDIANTE LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA DE DICHO COMPUESTO PARA INHIBIR LA VIA DE 5LIPOXIGENASA.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80859585A | 1985-12-12 | 1985-12-12 | |
| US80840785A | 1985-12-12 | 1985-12-12 | |
| US85687586A | 1986-04-28 | 1986-04-28 | |
| US06/856,928 US4719218A (en) | 1985-12-12 | 1986-04-28 | Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2056789T3 true ES2056789T3 (es) | 1994-10-16 |
Family
ID=27505832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES86309672T Expired - Lifetime ES2056789T3 (es) | 1985-12-12 | 1986-12-11 | Inhibicion de la ruta de la 5-lipoxigenasa. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0231622B1 (es) |
| AT (1) | ATE110387T1 (es) |
| AU (2) | AU609706B2 (es) |
| DE (1) | DE3650041T2 (es) |
| DK (1) | DK594086A (es) |
| ES (1) | ES2056789T3 (es) |
| FI (1) | FI865062A7 (es) |
| HU (1) | HU207077B (es) |
| IL (1) | IL80936A0 (es) |
| NO (1) | NO865011L (es) |
| NZ (1) | NZ218570A (es) |
| PT (1) | PT83916B (es) |
| ZW (1) | ZW24186A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145858A (en) * | 1985-12-12 | 1992-09-08 | Smithkline Beecham Corp. | Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| MY103766A (en) * | 1987-09-02 | 1993-09-30 | Smithkline Beckman Corp | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| GB8724566D0 (en) * | 1987-10-20 | 1987-11-25 | Roussel Lab Ltd | Chemical compounds |
| KR920702621A (ko) * | 1989-06-13 | 1992-10-06 | 스튜어트 알. 슈터 | 단핵세포 및/또는 마크로파지에 의한 인터루킨-1 또는 종양회사인자 생성의 억제 |
| KR930700104A (ko) * | 1990-06-12 | 1993-03-13 | 원본미기재 | 5-리프옥시게나제 및 사이클로옥시게나제 경로 개재된 질병의 억제 |
| US6358885B1 (en) | 1992-01-29 | 2002-03-19 | Mississippi State University | Substituted phenylheterocyclic herbicides |
| US5670455A (en) * | 1992-01-29 | 1997-09-23 | E. I. Du Pont De Nemours And Company | Substituted phenylheterocyclic herbicides |
| US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| DE10256881A1 (de) * | 2002-12-05 | 2004-06-24 | Beiersdorf Ag | Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten |
| PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| DK2731949T3 (en) * | 2011-07-13 | 2018-06-14 | Tiumbio Co Ltd | 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL131034C (es) * | 1964-05-11 | |||
| NL164285C (nl) * | 1968-01-09 | 1980-12-15 | Rhone Poulenc Sa | Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat. |
| GB1541321A (en) * | 1976-03-10 | 1979-02-28 | Metabio | 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation |
| US4263311A (en) * | 1976-09-27 | 1981-04-21 | Smithkline Corporation | 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles |
| LU77703A1 (de) * | 1977-07-07 | 1979-03-26 | Ciba Geigy Ag | Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen |
| US4153706A (en) * | 1978-02-13 | 1979-05-08 | Smithkline Corporation | 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles |
| US4175127A (en) * | 1978-09-27 | 1979-11-20 | Smithkline Corporation | Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles |
| CA1185020A (en) * | 1978-12-22 | 1985-04-02 | Geert C. Dijkhuis | Convectron thermonuclear reactor and process |
| US4186205A (en) * | 1979-01-08 | 1980-01-29 | Smithkline Corporation | 2,3-Di(4-substituted phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles |
| IL78834A (en) * | 1985-05-23 | 1992-07-15 | Smithkline Beckman Corp | 2,3-dihydro-5-(1,4-dihydropyridin-4-yl)-6-phenylimidazo(2,1-b)thiazoles and 6,7-dihydro-3-(1,4-dihydropyridin-4-yl)-2-phenyl-5h-imidazo(2,1-b)(1,3)thiazines and their use as intermediates in a process for preparing the corresponding pyridyl-substituted imidazo(2,1-b)thiazoles and 5h-imidazo(2,1-b)(1,3)thiazines |
-
1986
- 1986-12-08 ZW ZW241/86A patent/ZW24186A1/xx unknown
- 1986-12-09 NZ NZ218570A patent/NZ218570A/xx unknown
- 1986-12-10 DK DK594086A patent/DK594086A/da not_active Application Discontinuation
- 1986-12-10 IL IL80936A patent/IL80936A0/xx unknown
- 1986-12-10 HU HU865149A patent/HU207077B/hu not_active IP Right Cessation
- 1986-12-11 AT AT86309672T patent/ATE110387T1/de active
- 1986-12-11 NO NO865011A patent/NO865011L/no unknown
- 1986-12-11 PT PT83916A patent/PT83916B/pt not_active IP Right Cessation
- 1986-12-11 ES ES86309672T patent/ES2056789T3/es not_active Expired - Lifetime
- 1986-12-11 DE DE3650041T patent/DE3650041T2/de not_active Expired - Fee Related
- 1986-12-11 EP EP86309672A patent/EP0231622B1/en not_active Expired - Lifetime
- 1986-12-11 FI FI865062A patent/FI865062A7/fi not_active Application Discontinuation
- 1986-12-12 AU AU66455/86A patent/AU609706B2/en not_active Ceased
-
1991
- 1991-02-25 AU AU71367/91A patent/AU7136791A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK594086D0 (da) | 1986-12-10 |
| PT83916A (en) | 1987-01-01 |
| NO865011D0 (no) | 1986-12-11 |
| DE3650041T2 (de) | 1995-06-01 |
| NZ218570A (en) | 1989-08-29 |
| NO865011L (no) | 1987-06-15 |
| DK594086A (da) | 1987-06-13 |
| ZW24186A1 (en) | 1987-07-08 |
| HUT47106A (en) | 1989-01-30 |
| HU207077B (en) | 1993-03-01 |
| ATE110387T1 (de) | 1994-09-15 |
| EP0231622A2 (en) | 1987-08-12 |
| AU609706B2 (en) | 1991-05-09 |
| AU6645586A (en) | 1987-06-18 |
| FI865062A0 (fi) | 1986-12-11 |
| EP0231622A3 (en) | 1989-05-24 |
| PT83916B (pt) | 1989-05-12 |
| FI865062A7 (fi) | 1987-06-13 |
| AU7136791A (en) | 1991-05-09 |
| EP0231622B1 (en) | 1994-08-24 |
| DE3650041D1 (de) | 1994-09-29 |
| IL80936A0 (en) | 1987-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8722790A0 (it) | Composti farmacologicamente attivi, procedimenti per la loro preparazione e composizioni che li contengono. | |
| ES2063036T3 (es) | Compuestos (aralquil-sustituido) heterociclicos. | |
| ES2056789T3 (es) | Inhibicion de la ruta de la 5-lipoxigenasa. | |
| PY0101600A (es) | Compuesto oral antibacterial antiplaca | |
| GT199700009A (es) | Terapia combinada para la osteoporosis. | |
| EP0695171A1 (en) | GONADOTROPINE CONTAINING FREEZER DRIED DROPS | |
| ES2053510T3 (es) | Analogos de rebecamicina. | |
| TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
| ES2040231T3 (es) | Composiciones medicamentosas estables. | |
| KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
| MX9205574A (es) | Compuestos ciclicos utiles como inhibidores de la glicoproteina iib/iiia de las plaquetas y composiciones farmaceuticas que los contienen | |
| ES2169150T3 (es) | Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios. | |
| ES2054746T3 (es) | Aditivo para piensos estabilizado y procedimiento para su preparacion. | |
| NO870357D0 (no) | Skivekuttere for bergbrytemaskiner. | |
| CO5050328A1 (es) | Sistema solvente para la mejor penetracion de compuestos farmaceuticos | |
| IT8720619A0 (it) | Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
| MX9302034A (es) | Bencidazoles, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
| NO871954D0 (no) | Fuktsperre, spesielt til kabelinnfoeringer. | |
| ES2067906T3 (es) | Composiciones farmaceuticas de somatostatina con resorcion mejorada, su preparacion y uso. | |
| IT8522932A0 (it) | Derivati del flavolignano, procedimento per la loro preparazione e medicinali che contengono questi composti. | |
| IT8522359A0 (it) | Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori. | |
| MX9307047A (es) | Compuestos de quinazolinas y bencimidazoles substituidos. | |
| AT385879B (de) | Berg-, wander- od.dgl. -schuh | |
| NO20020914L (no) | Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav | |
| UY24915A1 (es) | Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 231622 Country of ref document: ES |